A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE study

Patricia Healy, Sanne J. Gordijn, Wessel Ganzevoort, Irene M. Beune, Ahmet Baschat, Asma Khalil, Louise Kenny, Frank H. Bloomfield, Mandy Daly, Jamie Kirkham, Declan Devane, Aris T. Papageorghiou

Research output: Contribution to journalArticle

Abstract

Background: Fetal growth restriction refers to a fetus that does not reach its genetically predetermined growth potential. It is well-recognized that growth-restricted fetuses are at increased risk of both short- and long-term adverse outcomes. Systematic evaluation of the evidence from clinical trials of fetal growth restriction is often difficult because of variation in the outcomes that are measured and reported. The development of core outcome sets for fetal growth restriction studies would enable future trials to measure similar meaningful outcomes. Objective: The purpose of this study was to develop core outcome sets for trials of prevention or treatment of fetal growth restriction. Study Design: This was a Delphi consensus study. A comprehensive literature review was conducted to identify outcomes that were reported in studies of prevention or treatment of fetal growth restriction. All outcomes were presented for prioritization to key stakeholders (135 healthcare providers, 68 researchers/academics, and 35 members of the public) in 3 rounds of online Delphi surveys. A priori consensus criteria were used to reach agreement on the final outcomes for inclusion in the core outcome set at a face-to-face meeting with 5 healthcare providers, 5 researchers/academics, and 6 maternity service users. Results: In total, 22 outcomes were included in the final core outcome set. These outcomes were grouped under 4 domains: maternal (n=4), fetal (n=1), neonatal (n=12), and childhood (n=5). Conclusion: The Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints study identified a large number of potentially relevant outcomes and then reached consensus on those factors that, as a minimum, should be measured and reported in all future trials of prevention or treatment of fetal growth restriction. This will enable future trials to measure similar meaningful outcomes and to ensure that findings from different studies can be compared and combined.

Original languageEnglish (US)
JournalAmerican journal of obstetrics and gynecology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Fetal Development
Health Personnel
Therapeutics
Fetus
Research Personnel
Delphi Technique
Growth
Mothers
Clinical Trials

Keywords

  • core outcome
  • fetal growth restriction
  • gestational age
  • pregnancy
  • trial

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

A Core Outcome Set for the prevention and treatment of fetal GROwth restriction : deVeloping Endpoints: the COSGROVE study. / Healy, Patricia; Gordijn, Sanne J.; Ganzevoort, Wessel; Beune, Irene M.; Baschat, Ahmet; Khalil, Asma; Kenny, Louise; Bloomfield, Frank H.; Daly, Mandy; Kirkham, Jamie; Devane, Declan; Papageorghiou, Aris T.

In: American journal of obstetrics and gynecology, 01.01.2019.

Research output: Contribution to journalArticle

Healy, P, Gordijn, SJ, Ganzevoort, W, Beune, IM, Baschat, A, Khalil, A, Kenny, L, Bloomfield, FH, Daly, M, Kirkham, J, Devane, D & Papageorghiou, AT 2019, 'A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE study', American journal of obstetrics and gynecology. https://doi.org/10.1016/j.ajog.2019.05.039
Healy, Patricia ; Gordijn, Sanne J. ; Ganzevoort, Wessel ; Beune, Irene M. ; Baschat, Ahmet ; Khalil, Asma ; Kenny, Louise ; Bloomfield, Frank H. ; Daly, Mandy ; Kirkham, Jamie ; Devane, Declan ; Papageorghiou, Aris T. / A Core Outcome Set for the prevention and treatment of fetal GROwth restriction : deVeloping Endpoints: the COSGROVE study. In: American journal of obstetrics and gynecology. 2019.
@article{4220113019dc4ac0baec5d39c2ec007f,
title = "A Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints: the COSGROVE study",
abstract = "Background: Fetal growth restriction refers to a fetus that does not reach its genetically predetermined growth potential. It is well-recognized that growth-restricted fetuses are at increased risk of both short- and long-term adverse outcomes. Systematic evaluation of the evidence from clinical trials of fetal growth restriction is often difficult because of variation in the outcomes that are measured and reported. The development of core outcome sets for fetal growth restriction studies would enable future trials to measure similar meaningful outcomes. Objective: The purpose of this study was to develop core outcome sets for trials of prevention or treatment of fetal growth restriction. Study Design: This was a Delphi consensus study. A comprehensive literature review was conducted to identify outcomes that were reported in studies of prevention or treatment of fetal growth restriction. All outcomes were presented for prioritization to key stakeholders (135 healthcare providers, 68 researchers/academics, and 35 members of the public) in 3 rounds of online Delphi surveys. A priori consensus criteria were used to reach agreement on the final outcomes for inclusion in the core outcome set at a face-to-face meeting with 5 healthcare providers, 5 researchers/academics, and 6 maternity service users. Results: In total, 22 outcomes were included in the final core outcome set. These outcomes were grouped under 4 domains: maternal (n=4), fetal (n=1), neonatal (n=12), and childhood (n=5). Conclusion: The Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints study identified a large number of potentially relevant outcomes and then reached consensus on those factors that, as a minimum, should be measured and reported in all future trials of prevention or treatment of fetal growth restriction. This will enable future trials to measure similar meaningful outcomes and to ensure that findings from different studies can be compared and combined.",
keywords = "core outcome, fetal growth restriction, gestational age, pregnancy, trial",
author = "Patricia Healy and Gordijn, {Sanne J.} and Wessel Ganzevoort and Beune, {Irene M.} and Ahmet Baschat and Asma Khalil and Louise Kenny and Bloomfield, {Frank H.} and Mandy Daly and Jamie Kirkham and Declan Devane and Papageorghiou, {Aris T.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ajog.2019.05.039",
language = "English (US)",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - A Core Outcome Set for the prevention and treatment of fetal GROwth restriction

T2 - deVeloping Endpoints: the COSGROVE study

AU - Healy, Patricia

AU - Gordijn, Sanne J.

AU - Ganzevoort, Wessel

AU - Beune, Irene M.

AU - Baschat, Ahmet

AU - Khalil, Asma

AU - Kenny, Louise

AU - Bloomfield, Frank H.

AU - Daly, Mandy

AU - Kirkham, Jamie

AU - Devane, Declan

AU - Papageorghiou, Aris T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Fetal growth restriction refers to a fetus that does not reach its genetically predetermined growth potential. It is well-recognized that growth-restricted fetuses are at increased risk of both short- and long-term adverse outcomes. Systematic evaluation of the evidence from clinical trials of fetal growth restriction is often difficult because of variation in the outcomes that are measured and reported. The development of core outcome sets for fetal growth restriction studies would enable future trials to measure similar meaningful outcomes. Objective: The purpose of this study was to develop core outcome sets for trials of prevention or treatment of fetal growth restriction. Study Design: This was a Delphi consensus study. A comprehensive literature review was conducted to identify outcomes that were reported in studies of prevention or treatment of fetal growth restriction. All outcomes were presented for prioritization to key stakeholders (135 healthcare providers, 68 researchers/academics, and 35 members of the public) in 3 rounds of online Delphi surveys. A priori consensus criteria were used to reach agreement on the final outcomes for inclusion in the core outcome set at a face-to-face meeting with 5 healthcare providers, 5 researchers/academics, and 6 maternity service users. Results: In total, 22 outcomes were included in the final core outcome set. These outcomes were grouped under 4 domains: maternal (n=4), fetal (n=1), neonatal (n=12), and childhood (n=5). Conclusion: The Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints study identified a large number of potentially relevant outcomes and then reached consensus on those factors that, as a minimum, should be measured and reported in all future trials of prevention or treatment of fetal growth restriction. This will enable future trials to measure similar meaningful outcomes and to ensure that findings from different studies can be compared and combined.

AB - Background: Fetal growth restriction refers to a fetus that does not reach its genetically predetermined growth potential. It is well-recognized that growth-restricted fetuses are at increased risk of both short- and long-term adverse outcomes. Systematic evaluation of the evidence from clinical trials of fetal growth restriction is often difficult because of variation in the outcomes that are measured and reported. The development of core outcome sets for fetal growth restriction studies would enable future trials to measure similar meaningful outcomes. Objective: The purpose of this study was to develop core outcome sets for trials of prevention or treatment of fetal growth restriction. Study Design: This was a Delphi consensus study. A comprehensive literature review was conducted to identify outcomes that were reported in studies of prevention or treatment of fetal growth restriction. All outcomes were presented for prioritization to key stakeholders (135 healthcare providers, 68 researchers/academics, and 35 members of the public) in 3 rounds of online Delphi surveys. A priori consensus criteria were used to reach agreement on the final outcomes for inclusion in the core outcome set at a face-to-face meeting with 5 healthcare providers, 5 researchers/academics, and 6 maternity service users. Results: In total, 22 outcomes were included in the final core outcome set. These outcomes were grouped under 4 domains: maternal (n=4), fetal (n=1), neonatal (n=12), and childhood (n=5). Conclusion: The Core Outcome Set for the prevention and treatment of fetal GROwth restriction: deVeloping Endpoints study identified a large number of potentially relevant outcomes and then reached consensus on those factors that, as a minimum, should be measured and reported in all future trials of prevention or treatment of fetal growth restriction. This will enable future trials to measure similar meaningful outcomes and to ensure that findings from different studies can be compared and combined.

KW - core outcome

KW - fetal growth restriction

KW - gestational age

KW - pregnancy

KW - trial

UR - http://www.scopus.com/inward/record.url?scp=85071115780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071115780&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2019.05.039

DO - 10.1016/j.ajog.2019.05.039

M3 - Article

C2 - 31152710

AN - SCOPUS:85071115780

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

ER -